换一批A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges, and future perspectives.
第一作者：
Ankaj,Kumar
第一单位：
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam 781101, India.
作者：
医学主题词
肺肿瘤(Lung Neoplasms);人类(Humans);动物(Animals);蛋白激酶抑制剂(Protein Kinase Inhibitors);投药, 吸入(Administration, Inhalation);抗肿瘤药(Antineoplastic Agents);药物释放系统(Drug Delivery Systems);纳米技术(Nanotechnology);纳米粒子(Nanoparticles);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);药物载体(Drug Carriers)
DOI
10.1016/j.ijpharm.2024.124745
PMID
39321904
发布时间
2024-11-18
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
